Mabaret Al-Asafara Hospitals
1 clinical trials · Sponsor
◉ Watch Mabaret Al-Asafara Hospitals
| Record | Firm | Date |
|---|---|---|
| Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic. (NCT04671589) | Mabaret Al-Asafara Hospitals | 2021-06-01 |
Track Mabaret Al-Asafara Hospitals automatically
Every clearance here is in the API, with alerts when new ones post.